PA
ASB icon

PharVision Advisers’s Associated Banc-Corp ASB Stock Holding History

PharVision Advisers’s Portfolio ASB Stock Details ASB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-13,755
Closed -$354K – 700
2025
Q3 		$354K Buy
+13,755
New +$353K 0.2% 137

Other funds holding ASB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

PharVision Advisers's ASB Position: Q4 2025 in Review

PharVision Advisers sold out of Associated Banc-Corp (ASB) in Q4 2025, closing a stake of 13,755 shares — an estimated $354K sold.

PharVision Advisers first reported a position in ASB in Q3 2025 and held it in 1 quarter. The position peaked at $354K in Q3 2025. 340 funds tracked by Wall St. Rank hold ASB as of Q4 2025.

  • PharVision Advisers reported no remaining Associated Banc-Corp position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 13,755 Associated Banc-Corp shares in Q4 2025, an estimated $354K.
  • PharVision Advisers first reported a position in Associated Banc-Corp in Q3 2025 and held it in 1 quarter.
  • PharVision Advisers's Associated Banc-Corp position peaked at $354K in Q3 2025.
  • 340 funds tracked by Wall St. Rank held Associated Banc-Corp as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.